Amarin Corp Plc (AMRN)

[couldbebetter]

JRoon71, One problem I always had with Amarin is that it was and still is unknown to the world.
For a BP to give its weight to any drug could make difference as to the success or failure of that
drug. That is why I so convinced that only a Eurocentric BP is capable of turning Vazkepa into
a success. Europe is the only place where Vazkepa has a long-term exclusivity arrangement
without a competing drug. I understand the rationale for Denner to wait at least for Germany
to reimburse. However, Denner needs this to be in the hands of a Eurocentric BP. GIA is suicide.
With or without Germany, France, & Italy; a Eurocentric BP will be needed. Too bad Astra-Zenica
did not acquire AMRN but went with an EPA/DHA mix. I would imagine AZN had some big plans
if their drug had been a success. Today, on another message board I came across a poster who
was just diagnosed with ALS. My grandfather died of ALS in the early 1960s and I had a High School
friend who died of ALS at a young age. Amarin tested Vascepa on ALS at a dose of 1 gram a day
and the study failed with a trend towards efficacy. So much wasted potential with this drug!